1. Home
  2. SEMR vs AVXL Comparison

SEMR vs AVXL Comparison

Compare SEMR & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEMR
  • AVXL
  • Stock Information
  • Founded
  • SEMR 2008
  • AVXL 2004
  • Country
  • SEMR United States
  • AVXL United States
  • Employees
  • SEMR N/A
  • AVXL N/A
  • Industry
  • SEMR EDP Services
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SEMR Technology
  • AVXL Health Care
  • Exchange
  • SEMR Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • SEMR 1.1B
  • AVXL 956.7M
  • IPO Year
  • SEMR 2021
  • AVXL N/A
  • Fundamental
  • Price
  • SEMR $7.41
  • AVXL $9.37
  • Analyst Decision
  • SEMR Buy
  • AVXL Strong Buy
  • Analyst Count
  • SEMR 8
  • AVXL 2
  • Target Price
  • SEMR $14.88
  • AVXL $44.00
  • AVG Volume (30 Days)
  • SEMR 1.2M
  • AVXL 987.3K
  • Earning Date
  • SEMR 11-06-2025
  • AVXL 08-12-2025
  • Dividend Yield
  • SEMR N/A
  • AVXL N/A
  • EPS Growth
  • SEMR N/A
  • AVXL N/A
  • EPS
  • SEMR N/A
  • AVXL N/A
  • Revenue
  • SEMR $413,962,000.00
  • AVXL N/A
  • Revenue This Year
  • SEMR $20.28
  • AVXL N/A
  • Revenue Next Year
  • SEMR $16.41
  • AVXL N/A
  • P/E Ratio
  • SEMR N/A
  • AVXL N/A
  • Revenue Growth
  • SEMR 22.16
  • AVXL N/A
  • 52 Week Low
  • SEMR $7.01
  • AVXL $5.03
  • 52 Week High
  • SEMR $18.74
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • SEMR 40.42
  • AVXL 45.30
  • Support Level
  • SEMR $7.32
  • AVXL $8.82
  • Resistance Level
  • SEMR $7.90
  • AVXL $10.40
  • Average True Range (ATR)
  • SEMR 0.23
  • AVXL 0.53
  • MACD
  • SEMR 0.02
  • AVXL 0.03
  • Stochastic Oscillator
  • SEMR 11.92
  • AVXL 34.81

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: